Neoadjuvant chemotherapy for advanced ovarian cancer: the tail of the scorpion for radical debulking surgery?-Reference-Cited by-同舟云学术

Neoadjuvant chemotherapy for advanced ovarian cancer: the tail of the scorpion for radical debulking surgery?

Published:2020-10-12 Issue:11 Volume:30 Page:1665-1666
ISSN:1048-891X
Container-title:International Journal of Gynecologic Cancer
language:en
Short-container-title:Int J Gynecol Cancer

Author:

Fotopoulou Christina^ORCID

Publisher

BMJ

Subject

Obstetrics and Gynecology,Oncology

Reference7 articles.

1. Maximal-effort cytoreductive surgery for ovarian cancer patients with a high tumor burden: variations in practice and impact on outcome;Hall;Ann Surg Oncol,2019

2. Fagotti A et.al . Randomized trial of primary debulking surgery versus neoadjuvant chemotherapy for advanced epithelial ovarian cancer (SCORPION-NCT01461850).

3. Neoadjuvant chemotherapy versus debulking surgery in advanced tubo-ovarian cancers: pooled analysis of individual patient data from the EORTC 55971 and CHORUS trials;Vergote;Lancet Oncol,2018

4. Value of neoadjuvant chemotherapy for newly diagnosed advanced ovarian cancer: a European perspective;Fotopoulou;J Clin Oncol,2017

5. Characteristics and survival of ovarian cancer patients treated with neoadjuvant chemotherapy but not undergoing interval debulking surgery;Liu;J Gynecol Oncol,2020

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Survival outcomes of primary vs interval cytoreductive surgery for International Federation of Gynecology and Obstetrics stage IV ovarian cancer: a nationwide population-based target trial emulation;American Journal of Obstetrics and Gynecology;2024-08

2. Does a high peritoneal cancer index lead to a worse prognosis of patients with advanced ovarian cancer?: a systematic review and meta-analysis based on the latest evidence;Frontiers in Oncology;2024-07-02

3. Prolonged Exposition with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) May Provide Survival Benefit after Cytoreductive Surgery (CRS) in Advanced Primary Epithelial Ovarian, Fallopian Tube, and Primary Peritoneal Cancer;Cancers;2022-07-06

4. Frailty Index for prediction of surgical outcome in ovarian cancer: Results of a prospective study;Gynecologic Oncology;2021-05

5. Insights into ovarian cancer care: report from the ANZGOG Ovarian Cancer Webinar Series 2020;Journal of Gynecologic Oncology;2021